Biosimilar Drugs – Improved Access and Health Economics with New Age Adaptations
What are Biosimilar Drugs? Filgrastim-sndz was the first Biosimilar to be approved by the US FDA in 2015. There has been active participation by the Pharmaceutical majors in the US and other parts of the world since this first approval. It was even estimated that six out of ten top drugs or products could be…
News Views